Day: February 26, 2021
MIDLAND, Tx., Feb. 26, 2021 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback” or the “Company”) today announced that it has completed its previously announced acquisition of leasehold interests and related oil and gas assets from Guidon Operating LLC, a portfolio company of Blackstone Energy Partners. Aggregate consideration consisted of $375 million in cash and 10.68 million shares of the Company’s common stock after accounting for post-effective date adjustments. As a result of the acquisition, Diamondback adds approximately 32,500 net acres in the Northern Midland Basin, primarily held by production allowing for capital efficient full field development.About Diamondback Energy, Inc.Diamondback is an independent oil and natural gas company headquartered in Midland, Texas focused on the acquisition, development,...
Titan Mining Updates Reporting at Mineral Ridge
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Feb. 26, 2021 (GLOBE NEWSWIRE) — Titan Mining Corporation (TSX: TI) (“Titan” or the “Company”) announces that in satisfying the reporting requirements of the British Columbia Securities Commission Titan commissioned an independent consultant to prepare a technical report on the Mineral Ridge Project.The technical report for Titan was based on a technical report with an effective date of January 2, 2018, summarizing a feasibility study that was prepared for Scorpio Gold Corporation (“Scorpio Gold”) on Mineral Ridge. The technical report prepared for Titan differs in some respects to that prepared for Scorpio Gold given the more recent effective date of the report of December 1, 2020, and includes the reclassification of the Measured Mineral Resources within the existing heap leach pad to Indicated Mineral...
Dividend Distribution Proposal
Written by Customer Service on . Posted in Public Companies.
Maranello (Italy), February 26, 2021 – Ferrari N.V. (NYSE/MTA: RACE) (the “Company”) announced today that its Board of Directors intends to recommend to the Company’s shareholders a dividend distribution to the holders of common shares of Euro 0.867 per common share, corresponding to a total distribution of approximately Euro 160 million.The distribution will be subject to its approval by the Annual General Meeting of Shareholders which is scheduled to be held on April 15, 2021.If shareholders approve the proposed dividend distribution, the ex-date is expected to be April 19, 2021, the record date April 20, 2021 on both MTA and NYSE and the payment date May 5, 2021.AttachmentFNV 2021 Dividend Distribution Proposal PR ENG
Orphazyme announces participation in upcoming virtual investor conferences
Written by Customer Service on . Posted in Public Companies.
Orphazyme A/SInvestor news No. 04/2021 Company Registration No. 32266355Copenhagen, Denmark and Chicago, IL, February 26, 2021 – Orphazyme A/S (ORPHA.CO; ORPH) (“the Company”), a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative rare diseases, today announced that Anders Vadsholt, interim CEO and CFO of Orphazyme, will be participating in the following upcoming investor conferences:Cowen Healthcare Conference, March 1-3, 2021:Panel discussion moderated by Cowen analysts Phil Nadeau, Ritu Baral and Boris Peaker entitled “New Drug Launches Panel” on Wednesday, March...
KludeIn I Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing March 1, 2021
Written by Customer Service on . Posted in Public Companies.
NEW YORK, NY, Feb. 26, 2021 (GLOBE NEWSWIRE) — KludeIn I Acquisition Corp. (NASDAQ: INKAU) (the “Company”) announced that, commencing March 1, 2021, holders of the units sold in the Company’s initial public offering may elect to separately trade shares of the Company’s Class A common stock (“Class A Common Stock”) and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Class A common stock and warrants that are separated will trade on the NASDAQ Capital Market under the symbols “INKA” and “INKAW,” respectively. Those units not separated will continue to trade on the NASDAQ Capital Market under the symbol “INKAU.”A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on...
Madison Pacific Properties Inc. (TSX: MPC and MPC.C) announces results of Annual General Meeting
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Feb. 26, 2021 (GLOBE NEWSWIRE) — Madison Pacific Properties Inc. (the Company), reports the voting results of the Annual General Meeting of its shareholders held February 25, 2021 in Vancouver, British Columbia.The following six nominees were re-elected as directors of the Company by the following votes:In addition, PricewaterhouseCoopers LLP was re-appointed as the auditor for the Company.About the Company: Madison Pacific Properties Inc. is a Vancouver-based real estate company with approximately $608 million in investment and development properties, including the Company’s proportionate share of properties held through jointly-controlled partnerships. The Company’s investment portfolio comprises 52 properties with approximately 1.83 million rentable sq. ft. of industrial and commercial space and a 50%...
Landmark Infrastructure Partners LP Announces 2020 K-1 Tax Package Availability
Written by Customer Service on . Posted in Public Companies.
EL SEGUNDO, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) — Landmark Infrastructure Partners LP (the “Partnership”) (NASDAQ: LMRK) today announced that it has completed the 2020 tax packages for unitholders of the Common Units (LMRK), Series A Preferred Units (LMRKP), Series B Preferred Units (LMRKO) and Series C Preferred Units (LMRKN), including the Schedule K-1. The tax packages are currently available online and may be accessed at www.taxpackagesupport.com/landmark or on LMRK’s website at www.landmarkmlp.com under “Investors/K-1 Tax Information”. The Partnership will begin printing and mailing the 2020 tax packages to all unitholders on March 1, 2021. For additional information or assistance, unitholders may contact Tax Package Support toll free at (844) 275-9872 (8 a.m. – 5 p.m. CT; Monday – Friday).About Landmark Infrastructure...
GLOBAL TECH INDUSTRIES GROUP, INC. RETIRES GENEVA ROTH REMARK HOLDINGS, INC. CONVERTIBLE DEBT.
Written by Customer Service on . Posted in Public Companies.
New York, New York, Feb. 26, 2021 (GLOBE NEWSWIRE) — (GTII: OTCQB) Global Tech Industries Group, Inc. (“GTII” or “Company”), www.gtii-us.com a development stage company, focused on acquiring new and innovative technologies in diverse industries, after quotation on the OTCQB marketplace, and retaining International Monetary for capital formation and support of its investor relations efforts, today announced that it has retired its convertible debt.GTII’s President, Kathy Griffin, stated, ”GTII takes great pleasure in announcing the full repayment of the convertible debt facility previously entered into last November, 2020. Our Board and our project team are working tirelessly to execute the company’s business plan. The company was accepted back onto the “QB” as of January, 2021, so this is a continuation of what we believe will be...
Adial Schedules Town Hall to Discuss Positive Updates Regarding Pharmaceutical Pipeline and Business Expansion
Written by Customer Service on . Posted in Public Companies.
CHARLOTTESVILLE, Va., Feb. 26, 2021 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial”), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that it will host a Town Hall at 1 P.M., Eastern Time on Thursday, March 18, 2021.Information for shareholders interested in attending will be available at the Company’s Investors section of the website: https://ir.adialpharma.com/About Adial Pharmaceuticals, Inc.Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) and is currently being investigated...
DIAGNOS Announces Exercise of Stock Warrants and Provides a Cash Update
Written by Customer Service on . Posted in Public Companies.
BROSSARD, Quebec, Feb. 26, 2021 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the exercise of 5,076,922 stock warrants within the past five months. The cash position of the Corporation as of today is $1,433,000.In the coming weeks, the Corporation expects to submit a first claim for disbursement under a financing agreement in the form of an interest-free loan of up to $2,000,000 from the government of Québec to support global commercialization. The financing agreement was initially announced on September 8th, 2020.The Corporation is also announcing a grant of 1,200,000 stock options to one of its directors. Stock options vest at 50% per...